Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
TEMPORARY TRACHEOBRONCHIAL STENTING IN MALIGNANT STENOSES
Autore:
WITT C; DINGES S; SCHMIDT B; EWERT R; BUDACH V; BAUMANN G;
Indirizzi:
HUMBOLDT UNIV BERLIN,MED SCH CHARITE,DEPT INTERNAL MED 1,DIV PNEUMOL,SCHUMANNSTR 20-21 D-10117 BERLIN GERMANY HUMBOLDT UNIV BERLIN,MED SCH CHARITE,DEPT RADIOTHERAPY D-10117 BERLINGERMANY
Titolo Testata:
European journal of cancer
fascicolo: 2, volume: 33, anno: 1997,
pagine: 204 - 208
SICI:
0959-8049(1997)33:2<204:TTSIMS>2.0.ZU;2-N
Fonte:
ISI
Lingua:
ENG
Soggetto:
SILICONE STENTS; AIRWAY-OBSTRUCTION; METAL STENT; TREE; MANAGEMENT; PALLIATION; TRACHEAL;
Keywords:
TEMPORARY STENTING; MALIGNANT STENOSES; STENT; INTERVENTIONAL PNEUMOLOGY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
22
Recensione:
Indirizzi per estratti:
Citazione:
C. Witt et al., "TEMPORARY TRACHEOBRONCHIAL STENTING IN MALIGNANT STENOSES", European journal of cancer, 33(2), 1997, pp. 204-208

Abstract

Endobronchial stent implantation has been successfully employed in malignant stenoses. The aim of this prospective study was to investigatethe temporary use of tracheobronchial stents combined with tumour-specific therapy. All patients received stents for primary palliation of dyspnoea followed by radio- or chemotherapy with the aim of stent removal after reduction of the stenosis. In 22 patients suffering from severe malignant strictures, 34 endobronchial stents (29 Strecker-, 3 Dumon-, 1 Orlowski-, 1 Dynamic-Y-stents) were implanted (in 9 patients, 2stents were necessary). Patients were treated by irradiation (n = 18)or chemotherapy (n = 4) after stent implantation. Significant improvement of dyspnoea (P < 0.001) and partial oxygen pressure (P < 0.01) was observed. In 11 out of 22 cases (50%), the stents could be removed after successful tumour-specific therapy which led to reduction of stenosis after a mean interval of 31.7 (6-104) days (temporary stenting). During the period of tumour-specific therapy, 9 patients died after a mean interval of 132 (13-347) days (definite stenting). In two cases, stents had to be removed after stent compression, stent dislocation and severe cough. The results suggest that temporary stenting, characterised by subsequent successful tumour-specific therapy, is a new valuable therapeutic strategy. It can ''bridge the gap'' before tumour-specific therapy can take effect. If tumour-specific therapy is ineffective, definite stenting is the palliative method of choice in severe dyspnoea in bronchial carcinoma. (C) 1997 Elsevier Science Ltd.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/09/20 alle ore 07:12:11